Medifast, Inc. recently published the earliest 34-week results from its one year and 34-week diabetes study directed by the Johns Hopkins Bloomberg School of Health. Medifast asked Dr. Cheskin to administer a Studyafter receiving reports from patients that helped control their diabetes symptoms. Compliance data that almost twice as many people on the Medifast for Diabetics program were able to complete the weight loss portion of the study. The other group was suggested to tag along a nutrit...
